国际检验医学杂志
國際檢驗醫學雜誌
국제검험의학잡지
International Journal of Laboratory Medicine
2015年
20期
2961-2962
,共2页
精神分裂症%换药治疗%血常规检查
精神分裂癥%換藥治療%血常規檢查
정신분렬증%환약치료%혈상규검사
schizophrenia%therapy change%routine blood tests
目的：探讨将氯丙嗪、氯氮平、奋乃静换为维思通治疗精神分裂症后患者血常规检查结果的改变情况。方法选取2014年3月至2015年3月于本院进行治疗的100例精神分裂症患者。患者先用氯丙嗪、氯氮平或奋乃静治疗一个疗程，然后换用维思通进行治疗。结果换药治疗后，患者的红细胞平均体积大于换药前。淋巴细胞计数多于换药前，中间细胞计数明显低于换药前，差异均有统计学意义（P＜0．05）。结论采用氯丙嗪、氯氮平或奋乃静治疗的精神分裂症患者改用维思通治疗后，白细胞分化有所改变，红细胞平均容积明显增大。
目的：探討將氯丙嗪、氯氮平、奮迺靜換為維思通治療精神分裂癥後患者血常規檢查結果的改變情況。方法選取2014年3月至2015年3月于本院進行治療的100例精神分裂癥患者。患者先用氯丙嗪、氯氮平或奮迺靜治療一箇療程，然後換用維思通進行治療。結果換藥治療後，患者的紅細胞平均體積大于換藥前。淋巴細胞計數多于換藥前，中間細胞計數明顯低于換藥前，差異均有統計學意義（P＜0．05）。結論採用氯丙嗪、氯氮平或奮迺靜治療的精神分裂癥患者改用維思通治療後，白細胞分化有所改變，紅細胞平均容積明顯增大。
목적：탐토장록병진、록담평、강내정환위유사통치료정신분렬증후환자혈상규검사결과적개변정황。방법선취2014년3월지2015년3월우본원진행치료적100례정신분렬증환자。환자선용록병진、록담평혹강내정치료일개료정，연후환용유사통진행치료。결과환약치료후，환자적홍세포평균체적대우환약전。림파세포계수다우환약전，중간세포계수명현저우환약전，차이균유통계학의의（P＜0．05）。결론채용록병진、록담평혹강내정치료적정신분렬증환자개용유사통치료후，백세포분화유소개변，홍세포평균용적명현증대。
Objective To study the blood routine tests results change after therapy of chlorpromazine ,clozapine ,perphenazine changed to risperidone in schizophrenic patients .Methods 100 schizophrenic patients in the hospital from March 2014 to March 2015 for treatment were enrolled in the study ,who were treated with chlorpromazine ,clozapine or perphenazine respectively for one course ,and then the therapies were replace by risperdal .Results After treatment ,mean corpuscular volume was significantly grea‐ter ,the number of lymphocytes was significantly higher and intermediate cell number was significantly lower than that before treat‐ment ,the difference was statistically significant(P<0 .05) .Conclusion Leukocyte differentiation change and mean corpuscular vol‐ume increased obviously after therapy of chlorpromazine ,clozapine or perphenazine changed to risperidone in schizophrenic patients .
